Nodality Lands $15,500,000 New Financing Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=7858bbe9-ef3d-4adf-96a1-2919dd382cbe&Preview=1 -
Date
3/22/2010 -
Company Name
Nodality -
Mailing Address
201 Gateway Blvd. South San Francisco, CA 94080 -
Company Description
Nodality Inc. is a privately held emerging biotechnology company focused on developing mechanistic
and patient-specific classification of disease. -
Website
http://www.nodalityinc.com -
Transaction Type
Venture Equity -
Transaction Amount
$15,500,000 -
Transaction Round
Undisclosed -
Proceeds Purposes
Proceeds from this financing will be used to support commercial activities associated with the company’s launch of its first test in acute myelogenous leukemia, as well as to advance ongoing and new research and development programs in other hematologic malignancies, autoimmune diseases, and solid tumors. -
M&A Terms
-
Venture Investor
Pfizer Strategic Investments Group -
Venture Investor
Kleiner Perkins Caufield & Byers -
Venture Investor
Maverick Capital -
Venture Investor
TPG Biotechnology Partners
